tirzepatide vs semaglutide weight loss mechanism efficacy A 72-week trial compared the two leading GLP-1 Ozempic® (semaglutide) and Mounjaro™ (tirzepatide),

People who are overweight (with a BMI of 27 or higher) with at least one weight-related condition, such as heart disease, high blood pressure, sleep apnea, or type 2 diabetes

Two patients on identical doses may experience very different appetite suppression and weight outcomes

Access to Experts: Many telehealth platforms connect users with healthcare providers specializing in obesity medicine, ensuring that treatment plans are evidence-based and tailored to patients needs

doi: 10.1016/j.pharep.2015.03.002

Taken together, our data uncovered a critical role of TMPRSS2 as an endogenous regulator of postprandial incretin levels and suggest that targeting TMPRSS2 may represent a potential interventional strategy to improve glucose homeostasis in existing obesity

Instead of relying on appetite or irregular eating patterns, building a simple daily structure can help support more balanced intake throughout the day